Dancing with the porcupine: Rules for governing the university-industry relationship

CMAJ. Canadian Medical Association Journal

Volumn 165, Issue 6, 2001, Pages 783-785

  Lewis, S ^a   Baird, P ^a   Evans, R G ^a   Ghali, W A ^a   Wright, C J ^a   Gibson, E ^a   Baylis, F ^a  

^a Access Consulting Ltd   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG APPROVAL; DRUG CONTROL; DRUG INDUSTRY; DRUG INFORMATION; DRUG MARKETING; DRUG RESEARCH; DRUG SYNTHESIS; GOVERNMENT; INTERPERSONAL COMMUNICATION; LAW; MEDICAL ETHICS; MEDICAL RESEARCH; NOTE; PATENT; POLICY; PROFIT; UNIVERSITY;

EID: 0034814597     PISSN: 08203946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (24)

1. The kept university
2. Academia and industry: Increasingly uneasy bedfellows
3. A national survey of policies on disclosure of conflicts of interest in biomedical research
4. Policies on faculty conflicts of interest at US universities
5. Conflict-of-interest policies for investigators in clinical trials
6. Scientific harassment by pharmaceutical companies: Time to stop
7. Health economists meet the fourth tempter: Drug dependency and scientific discourse
8. Drug firm suit fails to halt publication of Canadian health technology report
9. Bitter pill
10. Hospital denies that withdrawal of MD's job offer was related to drug-company funding
11. Lead donor Eli Lilly Canada launches education centre
12. What about the report?
13. Source of funding and outcome of clinical trials
14. Conflict of interest in the debate over calcium-channel antagonists
15. Evaluation of conflict of interest in economic analyses of new drugs used in oncology
16. The existence of publication bias and risk factors for its occurrence
17. Publication bias in clinical research
18. Meta-analysis and the meta-epidemiology of clinical research
19. Assessing faculty financial relationships with industry: A case study
20. University-industry partnership